医学
内科学
糖尿病
四分位间距
体质指数
优势比
1型糖尿病
肾病
2型糖尿病
视网膜病变
胃肠病学
糖化血红素
糖尿病性视网膜病变
超重
内分泌学
作者
Rebecca Helliwell,Harriet Warnes,Noppadol Kietsiriroje,Matthew D. Campbell,Rebecca Birch,Sam Pearson,Ramzi Ajjan
摘要
Abstract Aims To understand the relationship between insulin resistance (IR), assessed as estimated glucose disposal rate (eGDR), and microvascular/macrovascular complications in people with type 1 diabetes. Materials and methods Individuals with a confirmed diagnosis of type 1 diabetes were included in this cross‐sectional study. BMI was categorised into normal weight (18.0–24.9 kg m −2 ), overweight (25.0–29.9 kg m −2 ) and obese groups (≥30.0 kg m −2 ). We categorised eGDR into four groups: eGDR >8, 6–7.9, 4–5.9 and <4 mg kg −1 min −1 . Multiple logistic regression was used to identify associations with vascular complications, after adjusting for relevant confounders. Results A total of 2151 individuals with type 1 diabetes were studied. Median [interquartile range (IQR)] age was 41.0 [29.0, 55.0] with diabetes duration of 20.0 [11, 31] years. Odds ratio (OR) for retinopathy and nephropathy in obese compared with normal weight individuals was 1.64 (95% CI: 1.24–2.19; p = 0.001) and 1.62 (95% CI: 1.10–2.39; p = 0.015), while the association with cardiovascular disease just failed to reach statistical significance (OR 1.66 [95% CI: 0.97–2.86; p = 0.066]). Comparing individuals with eGDR ≥8 mg kg −1 min −1 and <4 mg kg −1 min −1 showed OR for retinopathy, nephropathy and macrovascular disease of 4.84 (95% CI: 3.36–6.97; p < 0.001), 8.35 (95% CI: 4.86–14.34; p < 0.001) and 13.22 (95% CI: 3.10–56.38; p < 0.001), respectively. Individuals with the highest eGDR category (≥8 mg kg −1 min −1 ) had the lowest complication rates irrespective of HbA 1c levels. Conclusions Obesity is prevalent in type 1 diabetes and diabetes complications are not only related to glucose control. IR, assessed as eGDR, is strongly associated with both microvascular and macrovascular complications, regardless of HbA 1c levels.
科研通智能强力驱动
Strongly Powered by AbleSci AI